ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO1833

RNA Sequencing Reveals Induction of Specific Renal Inflammatory Pathways in a Rat Model of Malignant Hypertension

Session Information

Category: Hypertension and CVD

  • 1403 Hypertension and CVD: Mechanisms

Authors

  • Hartner, Andrea, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Menendez-Castro, Carlos, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Cordasic, Nada, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Schiffer, Mario, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Veelken, Roland, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Amann, Kerstin U., Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Ekici, Arif, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Daniel, Christoph, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
  • Hilgers, Karl F., Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany
Background

In malignant hypertension (MH), far more severe kidney injury occurs than in the “benign” form of the disease. The pathogenesis of this peculiar renal injury of malignant hypertension remains incompletely understood. Using a rat model in which some but not all animals develop MH, we performed an unbiased analysis of gene expression by RNA-sequencing to identify transcriptional changes in the kidney specific for malignant hypertension.

Methods

Renovascular hypertension in rats was induced by placing a 0.2 mm clip on the left renal artery (2K1C). Five weeks later, all 2K1C rats had developed hypertension. Rats were then sacrificed, and renal cortical RNA was extracted from the right kidney exposed to high blood pressure. To distinguish MH from non-malignant hypertension (NMH), we considered two factors: weight loss and typical renovascular lesions.Differential gene expression was assessed in three groups: MH, NMH and normotensive, sham operated controls (N=5 per group for RNA sequencing, N between 8 and 14 for other analyses).

Results

Mean blood pressure measured intraarterially was elevated to a similar degree in MH (207±10 mmHg) and NMH (201±4 mmHg) compared to controls (113±3 mmHg, p<0.05). 886 genes were exclusively regulated in MH only. Principal component analysis revealed a separated clustering of the three groups. The data pointed to an upregulation of many inflammatory mechanisms in MH including pathways which previously attracted little attention in this setting: Transcripts from all three complement activation pathways were upregulated in MH compared to NMH but not in NMH compared with controls; immunohistochemistry confirmed complement deposition in MH exclusively. The expression of chemokines attracting neutrophil granulocytes as well as actual granulocyte infiltration were increased only in MH rats (CXCL6: 4.1-fold in MH over NMH).

Conclusion

The hypertensive kidney injury in malignant hypertension of 2K1C rats includes a robust expression and deposition of complement components as well as infiltration of neutrophil leukocytes, features which are not observed in the non-malignant course of renovascular hypertension. These pathways may contribute to the specific kidney injury observed in malignant hypertension.

Funding

  • Government Support – Non-U.S.